• Small molecule medical countermeasure research and development agency funding, legislation, appropriations, and oversight.
• Small molecule CBRN threat medical countermeasure research and development defense agency funding legislation, appropriations and oversight.
• Biodefense small molecule medical countermeasure against CBRN threats and orphan drug research and development funding, legislation, appropriations and oversight.

Duration: January 10, 2011 to November 30, 2011

General Issues: Homeland Security, Defense, Medical/Disease Research/Clinical Labs

Spending: about $52,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2011: House of Representatives, U.S. Senate, Centers For Disease Control & Prevention (CDC), Defense - Dept of (DOD), Defense Threat Reduction Agency (DTRA), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Homeland Security - Dept of (DHS), Natl Institutes of Health (NIH), White House Office,, Army - Dept of (Other) , Ballistic Missle Defense Organization, White House Office